The Tumor Cell Isolation Kits Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.5 billion by 2034, registering a CAGR of 11.5%. This growth trajectory is underpinned by several key factors, including the increasing prevalence of cancer, advancements in isolation technologies, and a growing emphasis on personalized medicine. The rising incidence of various cancers...